Management of specific symptom complexes in patients receiving palliative care

Bruera, Eduardo; Neumann, Catherine M.
June 1998
CMAJ: Canadian Medical Association Journal;06/30/98, Vol. 158 Issue 13, p1717
Academic Journal
Discusses the Canadian management of the most common symptoms of terminal cancer. The receiving of palliative care; Seven different cases of cancer patients; Cancer pain; The use of opioid agonists and adjuvant drugs; Cachexia-anorexia syndrome; The use of corticosteroids and progestational drugs; The multimodal approach; Chronic nausea; Asthenia; Delirium; Dyspnea; The use of oxygen, opioids, benzodiazepines, other drugs, and general support measures; Conclusions.


Related Articles

  • Recent Literature. Rousseau, Paul C. // Journal of Palliative Medicine;Winter1999, Vol. 2 Issue 4, p429 

    Compiles several studies on palliative care in the United States, which appeared in different medical journals. 'Cancer Pain Management,' by H.M. Chang; 'Opioids in Pain Management,' by H. McQuay; 'Assessment of Dyspnea in Advanced Cancer Patients,' by I. Mancini and J.J. Brody.

  • Improving Cancer Pain Management through a System Wide Commitment. Farber, Stuart; Andersen, Wes; Branden, Cherie; Isenhower, Peg; Lanier, Kay; O'Reilly, Linda // Journal of Palliative Medicine;Winter1998, Vol. 1 Issue 4, p377 

    Discusses strategies to improve cancer pain management through institutional approaches that contain quality assurance (QA) and quality improvement (QI) efforts. Description of an innovative pain management project; QA and QI efforts to improve and document performance.

  • Principles of palliative care and pain control. O'Neill, Bill; Fallon, Marie // BMJ: British Medical Journal (International Edition);09/27/97, Vol. 315 Issue 7111, p801 

    Discusses the principals of palliative care and cancer pain control. Development of palliative care; Components of palliative care; Allocation of resources to palliative care; Analgesic drugs; Opioid analgesics; Alternative routes to administration; Opioid alternatives to morphine; Tolerance...

  • Intrathecal chemical neurolysis for intractable cancer pain: a retrospective audit of 39 patients at a specialized cancer centre. Rehman, Saad Ur; Khan, Muhammad Zafar; Ahmed, Yaasir Ijaz; Rehman, Abdul // Anaesthesia, Pain & Intensive Care;Jul-Sep2015, Vol. 19 Issue 3, p287 

    Objectives: Treatment of cancer pain presents a challenging problem. Up to 90% of cancer patients can be treated with conventional pharmacological therapy. The remaining 10% of patients require additional interventions for management of their pain. Intrathecal chemical neurolysis (ICN) is a...

  • Intravenous morphine for emergency treatment of cancer pain. Suresh Kumar, K.; Rajagopal, M.; Naseema, A. // Palliative Medicine;May2000, Vol. 14 Issue 3, p183 

    Despite the wide use of the World Health Organization (WHO) analgesic ladder for the relief of cancer pain, it is not uncommon to find patients presenting with severe pain to palliative care centres. This is more so in the developing world, where facilities for pain relief are few and the health...

  • Differentiating neuropathic pain, opioid-induced hyperalgesia and opioid tolerance; considerations following a remarkable case. Kenter, Edward G.H.; Zylicz, Zbigniew // Advances in Palliative Medicine;2010, Vol. 9 Issue 3, p93 

    Most of the problems in pain control in end of life care are encountered due to three main syndromes or their combinations: neuropathic pain, opioid-induced hyperalgesia and opioid tolerance. In this article, we discuss a patient who was no longer responding to opioids and suffering severe pain,...

  • An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Mercadante, Sebastiano; Villari, Patrizia; Casuccio, Alessandra // Supportive Care in Cancer;Jul2011, Vol. 19 Issue 7, p979 

    recognition and treatment of breakthrough cancer pain (BcP) depend on the education and knowledge of palliative care physicians, it is important to systematically explore the attitudes of palliative care physicians in hospices or palliative care units. The aim of this study was to assess the...

  • Cervical intrathecal analgesia for head and neck/upper limb cancer pain: six case reports. Baker, Lisa; Balls, Jennifer; Regnard, Claud; Pridie, Angus // Palliative Medicine;Sep2007, Vol. 21 Issue 6, p543 

    We describe six cases of head and neck or upper limb cancer palliative care patients with refractory pain, treated with an intrathecal catheter placed at cervical or upper thoracic spinal levels with a non-implanted, externalized and tunnelled delivery system. In these cases, this system was...

  • The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain. Lasheen, Wael; Walsh, Declan; Mahmoud, Fade; Sarhill, Nabeel; Rivera, Nilo; Davis, Mellar; Lagman, Ruth; Legrand, Susan // Palliative Medicine;Jan2010, Vol. 24 Issue 1, p9 

    Morphine (M) is the opioid analgesic of choice for severe cancer pain. The IV to PO M equipotent switch ratio (CR) is controversial. We designed this prospective observational cohort to confirm the efficacy and safety of M IV to PO CR of 1:3. Consecutive cancer patients admitted to an inpatient...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics